{"disease":{"id":"maintenance-of-remission-of-ulcerative-colitis","name":"maintenance of remission of ulcerative colitis"},"drugs":{"marketed":[{"drug_id":"olsalazine","indication_name":"Maintenance of remission of ulcerative colitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"OLSALAZINE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":41,"revenue":null,"mechanism":"Olsalazine is converted to 5-ASA by colonic bacteria, which has a topical anti-inflammatory effect on colonic epithelial cells."}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}